Atossa Therapeutics, Inc. (ATOS)

USD 0.99

(-4.81%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 23 Thousand 8000.00 23 Thousand 46.6 Thousand 52.78 Thousand 44.19 Thousand
Gross Profit -23 Thousand -8000.00 -23 Thousand -46.6 Thousand -52.78 Thousand -44.19 Thousand
Operating Expenses 31.37 Million 27.69 Million 20.52 Million 14.6 Million 17.26 Million 11.43 Million
Selling, General and Administrative Expenses 14.04 Million 12.6 Million 11.31 Million 7.99 Million 10.62 Million 7.22 Million
Research and Development Expenses 17.33 Million 15.08 Million 9.21 Million 6.6 Million 6.64 Million 4.2 Million
Other Expenses - -146 Thousand -85 Thousand 50.8 Thousand 25.64 Thousand 29.29 Thousand
Cost and Expenses 31.37 Million 27.69 Million 20.52 Million 14.6 Million 17.26 Million 11.43 Million
Operating Income -31.37 Million -27.69 Million -20.52 Million -14.6 Million -17.26 Million -11.43 Million
Interest Expense - - - - - -
Income Tax Expense - -731 Thousand -213.55 Thousand 3.27 Million -119.07 Thousand -29.29 Thousand
Earnings before Tax -30.09 Million -26.96 Million -20.6 Million -17.82 Million -17.23 Million -11.4 Million
Net Income -30.09 Million -26.22 Million -20.6 Million -21.09 Million -17.23 Million -11.4 Million
Earnings Per Share Basic -0.24 -0.21 -0.18 -1.87 -2.03 -2.74
Earnings Per Share Diluted -0.24 -0.21 -0.18 -1.87 -2.03 -2.74
Weighted Average Shares Outstanding 126.08 Million 126.62 Million 116.95 Million 11.3 Million 8.49 Million 4.15 Million
Weighted Average Shares Outstanding (Diluted) 126.08 Million 126.62 Million 116.95 Million 11.3 Million 8.49 Million 4.15 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -31.35 Million -27.68 Million -20.49 Million -14.56 Million -17.21 Million -11.39 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts